GROWTH HORMONE FAMILY
Tesamorelin
Stabilized GHRH(1-44) analog. Studied in lipodystrophy and metabolic literature.
Bundle & save
Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility
Free shipping
on orders over $150
Damage protection
replacement guarantee
Secure checkout
256-bit SSL
Certificate of Analysis
Third-party tested · ISO/IEC 17025 accredited
99%
purity
✓ Passed full QC panel
- Variant
- Tesamorelin · 10 mg
- Lot #
- AML-2026-0517
- Labeled
- 10 mg
- Tested
- 2026-04-20
Full QC panel
- Purity (HPLC)
- 99%
- Net Peptide Content
- Pass
- Identity (HPLC-MS)
- Confirmed
- Heavy Metals (ICP-MS)
- Not detected
- Sterility
- No growth
- Endotoxin (LAL)
- Within limits
Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.
Compound Information
Chemical and structural properties
Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.
Molecular profile
Structure
- CAS Number
- 218949-48-5
- Molecular Formula
- C221H366N72O67S
- Molecular Weight
- 5136 g/mol
- Sequence
- (modified GHRH(1-44))
- Type
- Research peptide
- PubChem
- CID 16137828 ↗
Biological targets
Interactions
- Primary target
- Growth-hormone-releasing-hormone receptor (GHRHR)
- Pathway
- GHRHR–cAMP–GH release; IGF-1 axis
- Mechanism
- Stabilized GHRH(1–44) analog; stimulates endogenous GH secretion
- Research area
- Visceral adiposity, lipodystrophy, metabolic research
Physical properties
Handling & Storage
- Appearance
- White lyophilized powder
- Solubility
- Soluble in sterile water; reconstitute prior to use
- Storage
- 2-8 deg C, protect from light
- Country of origin
- USA
Sources & References
Peer-reviewed research
Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.
AIDS (LONDON, ENGLAND)
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors
2024 · PMID 38905488
Russo SC et al.
View Source ↗THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data
2010 · PMID 20554713
Falutz J et al.
View Source ↗JCI INSIGHT
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
2020 · PMID 32701508
Fourman LT et al.
View Source ↗DRUG TESTING AND ANALYSIS
Advances in the detection of growth hormone releasing hormone synthetic analogs
2021 · PMID 34665524
Memdouh S et al.
View Source ↗OBESITY RESEARCH & CLINICAL PRACTICE
Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials
2026 · PMID 41545261
Badran AS et al.
View Source ↗
⚠ Important research notice
PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.
All the research peptides you need, with the peace of mind at your fingertips.
Research updates from Aminologix
Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.